Journal profile · Biochemistry & Molecular Biology
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY
ISSN 0079-6107 · eISSN 1873-1732 · Elsevier Ltd · ENGLAND · Monthly · Founded 1963
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY: CAS Zone 3 · Biology (2025 upgraded edition); impact factor 4.5; hybrid open access; APC about USD 4,260; median 99 days to acceptance (105 articles, last 24 months); community-reported acceptance: fairly easy (Elsevier website: 93%); 46 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY is published by Elsevier Ltd and is in Zone 3 of Biology in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Cardiac electrophysiology and arrhythmias, Diverse Scientific and Economic Studies and Ion channel regulation and function, together about 28.6% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
Aims and Scope: Progress in Biophysics &Molecular Biology is an international review journal and covers the ground between the physical and biological sciences since its launch in 1950. It indicates to the physicist the great variety of unsolved problems awaiting attention in biology and medicine. The biologist and biochemist will find that this journal presents new and stimulating ideas and novel approaches to studying and influencing structural and functional properties of the living organism. This journal will be of particular interest to biophysicists, biologists, biochemists, cell physiologists, systems biologists, and molecular biologists. The purpose of the journal is to present invited, informative and critical reviews of recent advances in different aspects of biophysics and molecular biology. The Editors welcome suggestions of topics and potential authors. As the scope of Progress in Biophysics &Molecular Biology is wide and of interest to scientists in many disciplines, authors should treat their subject matter in a manner that is authoritative yet also easily comprehensible to those who are not experts in the field. Whilst the aim of the journal is primarily to publish substantial articles reviewing progress over an extensive field, review articles covering recent advances on more limited topics are also welcome. In addition, the journal publishes many Thematic Special Issues dedicated to specific areas of investigation - often linked to high-level international conferences - that contain both substantive reviews and original research papers.
From the journal's Aims & Scope
Research area (LetPub): Biochemistry & Molecular Biology
Editor-in-chief Delphine DeanPublisher website
Editorial board by country: none in mainland China; most named United States 4, Germany 3, Australia 3, United Kingdom 2, Italy 1 (15 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cardiac electrophysiology and arrhythmiasMedicine10.2%
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance9.6%
- Ion channel regulation and functionBiochemistry, Genetics and Molecular Biology8.8%
- Human auditory perception and evaluationEngineering8.6%
- Protein Structure and DynamicsBiochemistry, Genetics and Molecular Biology5.5%
- Enzyme Structure and FunctionMaterials Science4.6%
- Gene Regulatory Network AnalysisBiochemistry, Genetics and Molecular Biology4.2%
- Neuroscience and Neural EngineeringNeuroscience4.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Biology Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 3 |
| Minor | Biophysics | Zone 2 |
| Minor | Biochemistry & Molecular Biology | Zone 3 |
Top journal: noReview journal: yes
CAS Xinrui Journal Ranking (March 2026)Biology Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 2 |
| Minor | Biochemistry & Molecular Biology | Zone 3 |
| Minor | Biophysics | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Biology Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 3 |
| Minor | Biophysics | Zone 2 |
| Minor | Biochemistry & Molecular Biology | Zone 3 |
Top journal: noReview journal: yes
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 4.5LetPub ·
- Impact factor (publisher)
- 4.5Publisher website ·
- CiteScore 2026-06
- 9.6LetPub ·
- CiteScore (publisher)
- 9.6Publisher website ·
- SJR 2026-06
- 1LetPub ·
- SNIP 2026-06
- 1.32LetPub ·
- h-index
- 99LetPub ·
- h-index
- 175OpenAlex ·
- i10-index
- 1,644OpenAlex ·
- 2-year mean citedness
- 4.37OpenAlex ·
- Self-citation rate
- 2.2%LetPub ·
- Share of gold OA articles
- 19.35%LetPub ·
Volume
- Articles per year
- 42LetPub ·
Articles by year OpenAlex count · 3,485 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 59 | 19 | 25 |
| 2025 | 46 | 14 | 189 |
| 2024 | 58 | 19 | 499 |
| 2023 | 63 | 21 | 938 |
| 2022 | 89 | 18 | 1,191 |
| 2021 | 95 | 36 | 1,797 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
99 daysMedian, submission to acceptance · P25–P75 72 days – 140 days
- Acceptance to online
- median 1 days (105 articles)
- Submission to online
- median 100 days
- Sample
- 105 articles with submission and acceptance dates (118 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- 93%LetPub ·
- Submission to first decision
- 3 daysPublisher website ·
- First decision after review
- 55 daysPublisher website ·
- Submission to acceptance
- 102 daysPublisher website ·
- Acceptance to publication
- 2 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,260 / EUR 3,990 / GBP 3,410 / JPY 528,370 | — | — | |
| Publisher website | USD 4,430 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare2 items from the author guidelines
- Abstract
- ≤ 250 words
- Cover letter
- Required
Article types accepted4
- research articleProgress in Biophysics & Molecular Biology publishes review articles and in the thematic special issues usually a combination of review articles and research ar…Length not stated
- research articlesProgress in Biophysics & Molecular Biology publishes review articles and in the thematic special issues usually a combination of review articles and research ar…Length not stated
- review articleProgress in Biophysics & Molecular Biology publishes review articles and in the thematic special issues usually a combination of review articles and research ar…Length not stated
- review articlesProgress in Biophysics & Molecular Biology publishes review articles and in the thematic special issues usually a combination of review articles and research ar…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing allowed Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier Ltd
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Monthly
- Founded
- 1963
- ISSN
- 0079-6107
- Electronic ISSN
- 1873-1732
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY
What CAS zone is PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY in?
In the 2025 upgraded edition of the CAS Journal Ranking, PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY is in Zone 3 of Biology, and in Zone 2 of the minor category Biophysics / Biochemistry & Molecular Biology. In the 2026 Xinrui edition it is in Zone 2 of Biology. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY?
The latest impact factor listed by LetPub is 4.5; CiteScore 9.6, h-index 175.
How long does peer review take at PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY?
Based on the dates recorded on 105 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 99 days (interquartile range 72–140 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Fairly easy (Elsevier website: 93%)”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY?
According to the journal's author guidelines: Abstract: ≤ 250 words; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY based?
Of the 15 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (4), Germany (3) and Australia (3). Counted from the institutions listed on the board page; for reference only.
Which databases index PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY?
According to LetPub and DOAJ records, PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY is indexed in SCIE and Scopus.
Is PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY open access, and what is the APC?
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY is a hybrid journal. For open-access publication: APC about USD 4,260.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .